USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Search results for: '9561-B1'
-
This issue of Vital Signs, released on August 23, 2010, provides a strategic analysis of trends in biomarkers for improved and accelerated sepsis treatment. Additionally, a company spotlight is provided for BRAHMS, a global biotechnology company committed to improving healthcare through the discovery and development of novel and innovative bio...
$1,500.00
Special Price $1,125.00 save 25 %
-
15 Nov 2011 | North America | Market Research
Vital Signs - Healthcare News - The Analyst's Perspective (TAP)
This issue of Vital Signs, released on November 15, 2011, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Pharmaceuticals and Biotechnology, Medical Devices, Patient Monitoring, and Lifescience Tools.
$1,500.00
Special Price $1,125.00 save 25 %
-
24 May 2011 | North America | Market Research
Vital Signs - Healthcare News - The Analyst's Perspective (TAP)
This issue of Vital Signs, released on May 24, 2011, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Pharmaceuticals and Biotechnology, Medical Devices, Telehealth, and Medical Imaging.
$1,500.00
Special Price $1,125.00 save 25 %
-
$2,450.00
Special Price $1,837.50 save 25 %
-
23 Dec 2025 | North America | Market Research
North American Consumer Communication Services Tracker—First Quarter 2025 (Q1 25)
Subscriber, Revenue, Net Add (loss), Projection, and Market Share Tracker for Broadband, Video, Voice, and Wireless Services
The North American consumer communication services tracker for Q1 2025 provides detailed information about several consumer communication service companies in the United States and Canada. The aggregated data—delivered by country, technology, and company—includes subscriber, revenue, net add (loss), projection, and industry share for the residentia...
$2,450.00
